ALPHAEON Introduces skIN3, A New Cosmetic Line Featuring DermaTriPlex™, A Unique Technology That Can Significantly Reduce the Appearance of Fine Lines and Wrinkles
IRVINE, Calif., Feb. 2, 2016 /PRNewswire/ -- ALPHAEON Corporation, a social commerce company and subsidiary of Strathspey Crown Holdings LLC, today announced the launch of skIN3, a new line of products featuring DermaTriPlex™, a unique technology that can offer consumers a breakthrough option to address the ongoing challenges of the visual signs of aging.
The skIN3 line integrates three unique technology platforms – Novasome®, RHA Resilient Hyaluronic Acid®, and TruCollagen™. This unique combination is designed to significantly reduce the appearance of fine lines and wrinkles with the use of concentrated plant extracts that provide enhanced moisturizing and smoothing benefits.*
The DermaTriPlex technology, designed by board-certified plastic surgeon and equity holder in ALPHAEON and Strathspey Crown Holdings, Dr. Mark Pinsky, helps fight the appearance of fine lines and wrinkles by invigorating the skin with intensive moisture for plump-looking, smooth skin.* The DermaTriPlex technology includes more than twenty key ingredients that present a unique and unprecedented formula to offer a non-surgical option to those seeking a simple way to look their best. The skIN3 line includes day, night, eye and lip-care treatments that help preserve the youthful appearance of both skin and lips.
"I believe that regardless of the planned procedure, surgical or non surgical, the foundation to looking pretty is beautiful skin," said Dr. Mark Pinsky. "With that in mind, I worked with ALPHAEON to commercialize the DermaTriPlex technology and the full skIN3 line for patients who see wrinkles and fine lines as a concern, but are seeking an alternative and don't have time for a complex daily regimen."
"ALPHAEON has partnered with Dr. Pinsky on skIN3 to expand our beauty offerings for physicians looking to provide their patients with successful, non-surgical methods of managing the visual signs of aging skin," said September Riharb, Vice President of Marketing, ALPHAEON. "With this new line, ALPHAEON is making available the next generation of products designed to address the needs of patients everywhere who are seeking the best options in facial skincare. This underscores our commitment to delivering the best beauty solutions and is a true example of the intersection of technology innovation and beauty that we are striving to achieve."
ALPHAEON recommends speaking to a board-certified physician about these products. To learn more about the new line and find a physician who carries skIN3, please visit www.alphaeon.com.
About ALPHAEON Corporation
ALPHAEON Corporation is a social commerce company with the goal of transforming self-pay healthcare by bringing to market highly innovative products and services to promote consumer wellness, beauty and performance. The company works in partnership with board certified physicians ensuring access to leading advancements in lifestyle healthcare. For more information, please visit www.alphaeon.com.
About Strathspey Crown Holdings LLC
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. The firm is founded in partnership with physician investors across key medical specialties including plastic surgery, ophthalmology, dermatology, dentistry and orthopedics. For more information, please visit www.strathspeycrown.com.
ALPHAEON PRESS CONTACTS:
Jenna Mons Senior Vice President of Marketing and Communications
Tel: +1-904-343-3449
Email: [email protected]
Faith Paris, Spark for ALPHAEON
Tel: +1-646-291-6015
Email: [email protected]
*Data on File. ALPHAEON Corporation
DermaTriPlex™ is a trademark of Plastic Surgery Innovations, LLC
SOURCE ALPHAEON Corporation
Share this article